Primary cardiac angiosarcoma resection combined with right coronary artery bypass grafting

Naoyuki Ishigami1, Kimitoshi Horiba

  • 1Department of Cardiothoracic Surgery, Fujieda Municipal General Hospital, Fujieda, Shizuoka, Japan.

The Japanese Journal of Thoracic and Cardiovascular Surgery : Official Publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai Zasshi
|December 21, 2005
PubMed

Insights

A rare cardiac angiosarcoma in the right atrium was surgically removed and reconstructed. The patient recovered well, showing no recurrence 1.5 years post-surgery, highlighting successful aggressive treatment for primary cardiac tumors.

Area of Science:

  • Cardiovascular Surgery
  • Surgical Oncology
  • Cardiac Pathology

Background:

  • Primary cardiac tumors are rare, with angiosarcoma being an aggressive malignancy.
  • Cardiac tamponade can be a presenting symptom of advanced cardiac tumors.
  • Early diagnosis and aggressive surgical intervention are crucial for managing primary cardiac malignancies.

Observation:

  • A 41-year-old woman presented with symptoms suggestive of cardiac tamponade.
  • Diagnostic imaging revealed a primary malignant tumor in the right atrium without distant metastasis.
  • The tumor involved the right atrial wall, right coronary artery, and sinus node.

Findings:

  • Complete surgical resection of the right atrial angiosarcoma was achieved.
  • Reconstruction involved coronary artery bypass grafting and equine pericardium graft for the right atrial wall.
  • Pathological examination confirmed angiosarcoma as the final diagnosis.

Implications:

  • This case demonstrates the feasibility of aggressive surgical management for extensive right atrial angiosarcoma.
  • Successful reconstruction techniques, including bypass grafting and pericardial grafting, are vital for post-resection function.
  • Adjuvant radiotherapy may play a role in managing residual disease or preventing recurrence.
  • Long-term follow-up is essential to monitor for recurrence of this rare and aggressive cardiac tumor.